Agenus Inc

NASDAQ:AGEN 1:00:00 PM EDT

6.07

+0.56 (+10.16%)

4:42:07 PM EDT: $6.03 -0.04 (-0.66%)

Market Cap (Intraday)	166.42M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	6.01

See more stats

Estimates Current Quarter

Revenue	$39.68 Million
Adjusted EPS	$1.03

See more estimates

10-Day MA	$5.14
50-Day MA	$4.07
200-Day MA	$3.55

See more pivots

Agenus Inc Stock, NASDAQ:AGEN

3 Forbes Road, Lexington, Massachusetts 02421-7305

United States of America

Phone: +1.781.674.4400

Number of Employees: 316

http://www.agenusbio.com

Description

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.